Private Trust Co. NA Trims Stock Position in Humana Inc. $HUM

Private Trust Co. NA lessened its position in shares of Humana Inc. (NYSE:HUM) by 8.4% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 559 shares of the insurance provider’s stock after selling 51 shares during the period. Private Trust Co. NA’s holdings in Humana were worth $137,000 as of its most recent filing with the Securities and Exchange Commission.

Several other large investors have also recently bought and sold shares of HUM. Cary Street Partners Investment Advisory LLC increased its holdings in shares of Humana by 63.9% in the first quarter. Cary Street Partners Investment Advisory LLC now owns 118 shares of the insurance provider’s stock worth $31,000 after purchasing an additional 46 shares during the period. Zions Bancorporation National Association UT bought a new position in Humana in the 1st quarter worth about $37,000. Ransom Advisory Ltd purchased a new stake in shares of Humana in the 1st quarter valued at about $66,000. Transamerica Financial Advisors LLC raised its holdings in shares of Humana by 1,027.6% in the 1st quarter. Transamerica Financial Advisors LLC now owns 327 shares of the insurance provider’s stock valued at $87,000 after acquiring an additional 298 shares in the last quarter. Finally, Tower View Wealth Management LLC bought a new stake in shares of Humana during the 2nd quarter valued at about $88,000. 92.38% of the stock is owned by institutional investors.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on HUM. Truist Financial set a $300.00 price objective on shares of Humana in a research report on Tuesday, October 14th. Wall Street Zen lowered shares of Humana from a “buy” rating to a “hold” rating in a report on Saturday, August 2nd. Wolfe Research raised their price objective on shares of Humana from $283.00 to $313.00 and gave the company an “outperform” rating in a research report on Monday, October 6th. Morgan Stanley cut their target price on shares of Humana from $290.00 to $277.00 and set an “equal weight” rating for the company in a research report on Thursday, July 31st. Finally, Evercore ISI assumed coverage on Humana in a research report on Monday, September 22nd. They set an “in-line” rating and a $295.00 price target on the stock. Eight analysts have rated the stock with a Buy rating, ten have assigned a Hold rating and two have assigned a Sell rating to the company. According to data from MarketBeat, Humana currently has an average rating of “Hold” and an average price target of $297.58.

Humana Price Performance

HUM opened at $287.97 on Thursday. The company has a debt-to-equity ratio of 0.69, a current ratio of 1.95 and a quick ratio of 1.95. The stock’s 50 day simple moving average is $281.38 and its 200 day simple moving average is $258.81. The firm has a market cap of $34.63 billion, a price-to-earnings ratio of 22.10, a PEG ratio of 1.73 and a beta of 0.42. Humana Inc. has a 1 year low of $206.87 and a 1 year high of $315.35.

Humana (NYSE:HUM) last released its quarterly earnings data on Wednesday, July 30th. The insurance provider reported $6.27 earnings per share for the quarter, missing analysts’ consensus estimates of $6.32 by ($0.05). Humana had a net margin of 1.28% and a return on equity of 13.67%. The company had revenue of $32.39 billion for the quarter, compared to analysts’ expectations of $31.85 billion. During the same period last year, the company posted $6.96 EPS. The business’s revenue for the quarter was up 9.6% compared to the same quarter last year. Humana has set its FY 2025 guidance at 17.000- EPS. As a group, analysts predict that Humana Inc. will post 16.47 earnings per share for the current year.

Humana Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, October 31st. Shareholders of record on Friday, September 26th will be issued a $0.885 dividend. This represents a $3.54 dividend on an annualized basis and a yield of 1.2%. The ex-dividend date of this dividend is Friday, September 26th. Humana’s dividend payout ratio (DPR) is 27.17%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.